8,903
Total Claims
$2.0M
Drug Cost
929
Beneficiaries
$2,110
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+50%
Cost per patient vs peers
$2,110 vs $1,411 avg
+107%
Brand preference vs peers
22.0% vs 10.6% avg
Brand vs Generic
78% generic
Brand: 1,959 claims · $1.8M
Generic: 6,944 claims · $145K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sacubitril/Valsartan | 239 | $411K |
| Tafamidis | 12 | $273K |
| Empagliflozin | 351 | $230K |
| Apixaban | 139 | $214K |
| Rivaroxaban | 156 | $200K |
| Dabigatran Etexilate Mesylate | 595 | $183K |
| Evolocumab | 123 | $130K |
| Nitroglycerin | 11 | $57K |
| Ivabradine Hcl | 18 | $32K |
| Ticagrelor | 21 | $32K |
| Dronedarone Hcl | 14 | $24K |
| Icosapent Ethyl | 24 | $18K |
| Atorvastatin Calcium | 886 | $14K |
| Bisoprolol Fumarate | 366 | $12K |
| Clopidogrel Bisulfate | 441 | $8,775 |
Prescribing Profile
50
Unique Drugs
$1.1M
Patient Profile
77
Avg Age
43%
Female
1.89
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data